American Bio Medica Corporation
ABMC
$0.0001
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 725.00K | 912.00K | 1.25M | 1.66M | 2.00M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 725.00K | 912.00K | 1.25M | 1.66M | 2.00M |
| Cost of Revenue | 873.00K | 1.11M | 1.19M | 1.40M | 1.53M |
| Gross Profit | -148.00K | -194.00K | 69.00K | 263.00K | 472.00K |
| SG&A Expenses | 975.00K | 1.05M | 1.15M | 1.28M | 1.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.94M | 2.24M | 2.42M | 2.76M | 3.00M |
| Operating Income | -1.21M | -1.33M | -1.16M | -1.10M | -1.00M |
| Income Before Tax | 852.00K | -1.41M | -1.42M | -439.00K | -284.00K |
| Income Tax Expenses | 2.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Earnings from Continuing Operations | 0.85 | -1.41 | -1.42 | -0.44 | -0.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 850.00K | -1.41M | -1.42M | -441.00K | -286.00K |
| EBIT | -1.21M | -1.33M | -1.16M | -1.10M | -1.00M |
| EBITDA | -1.17M | -1.28M | -1.11M | -1.05M | -938.00K |
| EPS Basic | 0.02 | -0.03 | -0.03 | -0.01 | 0.00 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | 0.01 | -0.04 | -0.03 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 192.39M | 192.07M | 197.17M | 193.09M | 185.94M |
| Average Diluted Shares Outstanding | 192.39M | 192.07M | 197.17M | 193.09M | 185.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |